Jennifer N. Lind

发表

Maternal Medication Use and Risk of Hypospadias- An Exposure Spectrum Approach

J. Lind, Jennifer N. Lind, 2012 .

Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007

M. Werler, J. Reefhuis, M. Honein, 2013, Pharmacoepidemiology and drug safety.

Maternal Prepregnancy Body Mass Index and Child Psychosocial Development at 6 Years of Age

L. Schieve, S. Hinkle, J. Lind, 2015, Pediatrics.

Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review

Meghan T. Frey, N. Dowling, S. Gilboa, 2017, Pediatrics.

Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures.

M. Lovegrove, N. Weidle, J. Lind, 2023, American journal of preventive medicine.

US Emergency Department Visits Attributed to Medication Harms, 2017-2019.

D. Pollock, Nadine Shehab, M. Lovegrove, 2021, JAMA.

Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016-2017.

M. Lovegrove, R. Moro, N. Weidle, 2020, American journal of preventive medicine.

Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review

Meghan T. Frey, N. Dowling, S. Gilboa, 2017, Pediatrics.

Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

Jean Y. Ko, W. Barfield, J. Lind, 2016, MMWR. Morbidity and mortality weekly report.

Opioid prescription claims among women aged 15-44 years-United States, 2013-2017.

Meghan T. Frey, Jean Y. Ko, S. Gilboa, 2021, Journal of opioid management.

Using Supervised Learning Methods to Develop a List of Prescription Medications of Greatest Concern during Pregnancy

Meghan T. Frey, S. Gilboa, J. Reefhuis, 2020, Maternal and Child Health Journal.

Breastfeeding and Later Psychosocial Development of Children at 6 Years of Age

L. Schieve, J. Lind, Ruowei Li, 2014, Pediatrics.

Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.

A. Mitchell, W. Bobo, J. Reefhuis, 2020, JAMA psychiatry.

ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998-2011

S. Visser, S. Farr, J. Reefhuis, 2020, Journal of Attention Disorders.

Atypical antipsychotic use during pregnancy and birth defect risk: National Birth Defects Prevention Study, 1997–2011

W. Bobo, R. Bitsko, J. Reefhuis, 2019, Schizophrenia Research.

Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.

M. Werler, S. Gilboa, J. Lind, 2017, Annals of epidemiology.

Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015

S. Farr, J. Lind, M. Danielson, 2018, MMWR. Morbidity and mortality weekly report.

US emergency department visits for acute harms from over‐the‐counter cough and cold medications, 2017–2019

Rohan Mital, M. Lovegrove, R. Moro, 2021, Pharmacoepidemiology and drug safety.

Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic

Nadine Shehab, M. Lovegrove, A. Geller, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists

Meghan T. Frey, L. Squiers, S. Gilboa, 2017, Qualitative health research.

Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk

S. Hernández-Díaz, A. Mitchell, S. Gilboa, 2013, Pharmacoepidemiology and drug safety.

Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web‐based information, 2011

C. Moore, J. Friedman, M. Honein, 2013, Pharmacoepidemiology and drug safety.

Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies

Meghan T. Frey, L. Squiers, S. Gilboa, 2017, Maternal and Child Health Journal.

Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012

Meghan T. Frey, S. Gilboa, M. Honein, 2015, MMWR. Morbidity and mortality weekly report.

Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013.

S. Gilboa, S. Farr, J. Reefhuis, 2016, MMWR. Morbidity and mortality weekly report.

Oxymorphone HCl (Opana) for the Relief of Moderate-to-Severe Pain

J. Lind, P. Ghazvini, J. Lennard, 2007 .

Racial Disparities in Access to Maternity Care Practices That Support Breastfeeding — United States, 2011

L. Grummer-Strawn, J. Lind, C. Perrine, 2014, MMWR. Morbidity and mortality weekly report.

Prenatal breastfeeding counseling--Pregnancy Risk Assessment Monitoring System, United States, 2010.

L. Grummer-Strawn, I. Ahluwalia, Leslie L. Harrison, 2014, MMWR supplements.

Relationship between Use of Labor Pain Medications and Delayed Onset of Lactation

Ruowei Li, Cria G. Perrine, Jennifer N. Lind, 2014, Journal of human lactation : official journal of International Lactation Consultant Association.

Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome — Six States, 2013–2017

Angela M. Miller, Meghan T. Frey, J. Gilchrist, 2019, MMWR. Morbidity and mortality weekly report.

Assessing the Burden of Neonatal Abstinence Syndrome: Validation of ICD-9-CM Data, Florida, 2010-2011

A. Creanga, J. Lind, W. Sappenfield, 2020, Journal of public health management and practice : JPHMP.

Leveraging Existing Birth Defects Surveillance Infrastructure to Build Neonatal Abstinence Syndrome Surveillance Systems — Illinois, New Mexico, and Vermont, 2015–2016

J. Reefhuis, J. Lind, E. Ailes, 2019, MMWR. Morbidity and mortality weekly report.

Infant and Maternal Characteristics in Neonatal Abstinence Syndrome — Selected Hospitals in Florida, 2010–2011

C. Blackmore, A. Creanga, W. Sappenfield, 2015, MMWR. Morbidity and mortality weekly report.